Tonix Pharmaceuticals Holding Corp. ·
TNXP 8-K 2026-10-02
Tonix Pharmaceuticals Holding Corp. (TNXP) 8-K dated 2026-10-02 — accession 0001493152-26-045603.
Tonix Pharmaceuticals Holding Corp. (TNXP) is a biotechnology company listed on NASDAQ.
Tonix Pharmaceuticals Holding Corp. filed a 8-K on 2026-10-02. Accession 0001493152-26-045603.
This 8-K covers: Other events (Item 8.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported TNXP revenue for 2025-12-31 was $13.1M. Net income was -$124.0M. Revenue was up 29.8% from 2024-12-31 to 2025-12-31. TNXP currently screens at market cap $194.5M.
Not investment advice. The TNXP SEC hub lists recent forms. The stock page is the research view.